ONCOL REP 润色咨询

ONCOLOGY REPORTS

出版年份:1994 年文章数:5979 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:5.3% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1096197, encodeId=bdfb109619eda, content=引言中如何全面包含本领域重要研究?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096198, encodeId=31cf10961987b, content=引言中是否可以引用非常老的文章?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534677, encodeId=9eb55346e702, content=恭喜恭喜 太不容易了<span class="quote">Freemori7JR 2017-03-20 发表::<br>研究方向:黑素瘤;; 接收率:约50% 审稿时间:约1个月 7.26投稿;8.30——通知大修;10.25——大修返回;10.31——Further comments; 11.05——返回编辑部;11.12——通知接收;17.01.03——收到Proof;17.03.10——Early Online; 17.03.20——Publish. </span>, beContent=Freemori7JR 2017-03-20 发表:: 研究方向:黑素瘤;; 接收率:约50% 审稿时间:约1个月 7.26投稿;8.30——通知大修;10.25——大修返回;10.31——Further comments; 11.05——返回编辑部;11.12——通知接收;17.01.03——收到Proof;17.03.10——Early Online; 17.03.20——Publish. , objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151023/IMG5629A2D78CDB25049.jpg, createdBy=12251658553, createdName=sugar661930, createdTime=Sat Mar 25 10:01:00 CST 2017, time=2017-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574022, encodeId=af555e4022b8, content=这个杂志大概外审2个月,回来后要大修,补实验补了一个月,返回后大概过了一个星期,给了Futher commons, 大概改了一个星期修回,但现在还木有消息,想问一下大家都是什么时候接受的,会不会被编辑拒稿呀,好忐忑,求大神指点,十分感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLC6axn6gYictvvbVm0tkM8YjTrvDLLhwvlqibMFQtAfjby2AY4UHAIPKnSqH1Ovp5AgCJY6Ldx6BDw/132, createdBy=bf3b2187804, createdName=Nelly 1993, createdTime=Thu Jul 25 15:43:00 CST 2019, time=2019-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977749, encodeId=ec809e7749af, content=五月十四投的,六月三号给的反馈意见,小修加润色。编辑部要润色证明。然后找了国内的唐山博译润色。结果今天提交后秒拒。这个编辑部把博译相关的润色公司列入黑名单了,而且是秒拒那种。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08bc5311998, createdName=amma229, createdTime=Mon Jun 28 22:57:23 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913998, encodeId=ff3391399829, content=被中科院列为中度预警的期刊,投这个还能毕业吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d375190834, createdName=14717fcdm36(暂无昵称), createdTime=Tue Jan 05 22:34:16 CST 2021, time=2021-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893480, encodeId=7243893480f7, content=想问一下各位,这个杂志submitted状态之后直接是under review吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201025/8eb3ba664d3e470b851a46cc65b07783/2838e99db9824e3ab062239a32b94ea0.jpg, createdBy=e8705227503, createdName=14792e5am71(暂无昵称), createdTime=Wed Oct 21 09:53:30 CST 2020, time=2020-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884742, encodeId=2d12884e4237, content=刚提交了这个杂志,请问后续过程快吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Sat Sep 12 12:12:11 CST 2020, time=2020-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812178, encodeId=d4c88121e89a, content=收综述嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/f0a941924e706deff67f804425f96db6/7b6b2aabb706f19d41b6dc3d8aef6e5c.jpg, createdBy=947b2378049, createdName=wh66ksbs, createdTime=Sat Aug 22 21:58:13 CST 2020, time=2020-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576784, encodeId=16e85e678449, content=是的<span class="quote">135****0862暂无昵称 2019-09-22 00:00:00 发表:<br>这个杂志是非OA期刊也要交版面费?</span>, beContent=135****0862暂无昵称 2019-09-22 00:00:00 发表: 这个杂志是非OA期刊也要交版面费?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/141c3b405ac632875dc5e2f757c9755d.jpg, createdBy=d8912207664, createdName=1085404196_71099776, createdTime=Mon Sep 23 00:00:00 CST 2019, time=2019-09-23, status=1, ipAttribution=)]
    2021-12-27 桑晒麦拉

    引言中如何全面包含本领域重要研究?

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1096197, encodeId=bdfb109619eda, content=引言中如何全面包含本领域重要研究?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096198, encodeId=31cf10961987b, content=引言中是否可以引用非常老的文章?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534677, encodeId=9eb55346e702, content=恭喜恭喜 太不容易了<span class="quote">Freemori7JR 2017-03-20 发表::<br>研究方向:黑素瘤;; 接收率:约50% 审稿时间:约1个月 7.26投稿;8.30——通知大修;10.25——大修返回;10.31——Further comments; 11.05——返回编辑部;11.12——通知接收;17.01.03——收到Proof;17.03.10——Early Online; 17.03.20——Publish. </span>, beContent=Freemori7JR 2017-03-20 发表:: 研究方向:黑素瘤;; 接收率:约50% 审稿时间:约1个月 7.26投稿;8.30——通知大修;10.25——大修返回;10.31——Further comments; 11.05——返回编辑部;11.12——通知接收;17.01.03——收到Proof;17.03.10——Early Online; 17.03.20——Publish. , objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151023/IMG5629A2D78CDB25049.jpg, createdBy=12251658553, createdName=sugar661930, createdTime=Sat Mar 25 10:01:00 CST 2017, time=2017-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574022, encodeId=af555e4022b8, content=这个杂志大概外审2个月,回来后要大修,补实验补了一个月,返回后大概过了一个星期,给了Futher commons, 大概改了一个星期修回,但现在还木有消息,想问一下大家都是什么时候接受的,会不会被编辑拒稿呀,好忐忑,求大神指点,十分感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLC6axn6gYictvvbVm0tkM8YjTrvDLLhwvlqibMFQtAfjby2AY4UHAIPKnSqH1Ovp5AgCJY6Ldx6BDw/132, createdBy=bf3b2187804, createdName=Nelly 1993, createdTime=Thu Jul 25 15:43:00 CST 2019, time=2019-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977749, encodeId=ec809e7749af, content=五月十四投的,六月三号给的反馈意见,小修加润色。编辑部要润色证明。然后找了国内的唐山博译润色。结果今天提交后秒拒。这个编辑部把博译相关的润色公司列入黑名单了,而且是秒拒那种。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08bc5311998, createdName=amma229, createdTime=Mon Jun 28 22:57:23 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913998, encodeId=ff3391399829, content=被中科院列为中度预警的期刊,投这个还能毕业吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d375190834, createdName=14717fcdm36(暂无昵称), createdTime=Tue Jan 05 22:34:16 CST 2021, time=2021-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893480, encodeId=7243893480f7, content=想问一下各位,这个杂志submitted状态之后直接是under review吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201025/8eb3ba664d3e470b851a46cc65b07783/2838e99db9824e3ab062239a32b94ea0.jpg, createdBy=e8705227503, createdName=14792e5am71(暂无昵称), createdTime=Wed Oct 21 09:53:30 CST 2020, time=2020-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884742, encodeId=2d12884e4237, content=刚提交了这个杂志,请问后续过程快吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Sat Sep 12 12:12:11 CST 2020, time=2020-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812178, encodeId=d4c88121e89a, content=收综述嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/f0a941924e706deff67f804425f96db6/7b6b2aabb706f19d41b6dc3d8aef6e5c.jpg, createdBy=947b2378049, createdName=wh66ksbs, createdTime=Sat Aug 22 21:58:13 CST 2020, time=2020-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576784, encodeId=16e85e678449, content=是的<span class="quote">135****0862暂无昵称 2019-09-22 00:00:00 发表:<br>这个杂志是非OA期刊也要交版面费?</span>, beContent=135****0862暂无昵称 2019-09-22 00:00:00 发表: 这个杂志是非OA期刊也要交版面费?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/141c3b405ac632875dc5e2f757c9755d.jpg, createdBy=d8912207664, createdName=1085404196_71099776, createdTime=Mon Sep 23 00:00:00 CST 2019, time=2019-09-23, status=1, ipAttribution=)]
    2021-12-28 小动量

    引言中是否可以引用非常老的文章?

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1096197, encodeId=bdfb109619eda, content=引言中如何全面包含本领域重要研究?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096198, encodeId=31cf10961987b, content=引言中是否可以引用非常老的文章?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534677, encodeId=9eb55346e702, content=恭喜恭喜 太不容易了<span class="quote">Freemori7JR 2017-03-20 发表::<br>研究方向:黑素瘤;; 接收率:约50% 审稿时间:约1个月 7.26投稿;8.30——通知大修;10.25——大修返回;10.31——Further comments; 11.05——返回编辑部;11.12——通知接收;17.01.03——收到Proof;17.03.10——Early Online; 17.03.20——Publish. </span>, beContent=Freemori7JR 2017-03-20 发表:: 研究方向:黑素瘤;; 接收率:约50% 审稿时间:约1个月 7.26投稿;8.30——通知大修;10.25——大修返回;10.31——Further comments; 11.05——返回编辑部;11.12——通知接收;17.01.03——收到Proof;17.03.10——Early Online; 17.03.20——Publish. , objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151023/IMG5629A2D78CDB25049.jpg, createdBy=12251658553, createdName=sugar661930, createdTime=Sat Mar 25 10:01:00 CST 2017, time=2017-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574022, encodeId=af555e4022b8, content=这个杂志大概外审2个月,回来后要大修,补实验补了一个月,返回后大概过了一个星期,给了Futher commons, 大概改了一个星期修回,但现在还木有消息,想问一下大家都是什么时候接受的,会不会被编辑拒稿呀,好忐忑,求大神指点,十分感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLC6axn6gYictvvbVm0tkM8YjTrvDLLhwvlqibMFQtAfjby2AY4UHAIPKnSqH1Ovp5AgCJY6Ldx6BDw/132, createdBy=bf3b2187804, createdName=Nelly 1993, createdTime=Thu Jul 25 15:43:00 CST 2019, time=2019-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977749, encodeId=ec809e7749af, content=五月十四投的,六月三号给的反馈意见,小修加润色。编辑部要润色证明。然后找了国内的唐山博译润色。结果今天提交后秒拒。这个编辑部把博译相关的润色公司列入黑名单了,而且是秒拒那种。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08bc5311998, createdName=amma229, createdTime=Mon Jun 28 22:57:23 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913998, encodeId=ff3391399829, content=被中科院列为中度预警的期刊,投这个还能毕业吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d375190834, createdName=14717fcdm36(暂无昵称), createdTime=Tue Jan 05 22:34:16 CST 2021, time=2021-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893480, encodeId=7243893480f7, content=想问一下各位,这个杂志submitted状态之后直接是under review吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201025/8eb3ba664d3e470b851a46cc65b07783/2838e99db9824e3ab062239a32b94ea0.jpg, createdBy=e8705227503, createdName=14792e5am71(暂无昵称), createdTime=Wed Oct 21 09:53:30 CST 2020, time=2020-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884742, encodeId=2d12884e4237, content=刚提交了这个杂志,请问后续过程快吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Sat Sep 12 12:12:11 CST 2020, time=2020-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812178, encodeId=d4c88121e89a, content=收综述嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/f0a941924e706deff67f804425f96db6/7b6b2aabb706f19d41b6dc3d8aef6e5c.jpg, createdBy=947b2378049, createdName=wh66ksbs, createdTime=Sat Aug 22 21:58:13 CST 2020, time=2020-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576784, encodeId=16e85e678449, content=是的<span class="quote">135****0862暂无昵称 2019-09-22 00:00:00 发表:<br>这个杂志是非OA期刊也要交版面费?</span>, beContent=135****0862暂无昵称 2019-09-22 00:00:00 发表: 这个杂志是非OA期刊也要交版面费?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/141c3b405ac632875dc5e2f757c9755d.jpg, createdBy=d8912207664, createdName=1085404196_71099776, createdTime=Mon Sep 23 00:00:00 CST 2019, time=2019-09-23, status=1, ipAttribution=)]
    2017-03-25 sugar661930

    恭喜恭喜 太不容易了Freemori7JR 2017-03-20 发表::
    研究方向:黑素瘤;; 接收率:约50% 审稿时间:约1个月 7.26投稿;8.30——通知大修;10.25——大修返回;10.31——Further comments; 11.05——返回编辑部;11.12——通知接收;17.01.03——收到Proof;17.03.10——Early Online; 17.03.20——Publish.

    Freemori7JR 2017-03-20 发表:: 研究方向:黑素瘤;; 接收率:约50% 审稿时间:约1个月 7.26投稿;8.30——通知大修;10.25——大修返回;10.31——Further comments; 11.05——返回编辑部;11.12——通知接收;17.01.03——收到Proof;17.03.10——Early Online; 17.03.20——Publish.

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=1096197, encodeId=bdfb109619eda, content=引言中如何全面包含本领域重要研究?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096198, encodeId=31cf10961987b, content=引言中是否可以引用非常老的文章?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534677, encodeId=9eb55346e702, content=恭喜恭喜 太不容易了<span class="quote">Freemori7JR 2017-03-20 发表::<br>研究方向:黑素瘤;; 接收率:约50% 审稿时间:约1个月 7.26投稿;8.30——通知大修;10.25——大修返回;10.31——Further comments; 11.05——返回编辑部;11.12——通知接收;17.01.03——收到Proof;17.03.10——Early Online; 17.03.20——Publish. </span>, beContent=Freemori7JR 2017-03-20 发表:: 研究方向:黑素瘤;; 接收率:约50% 审稿时间:约1个月 7.26投稿;8.30——通知大修;10.25——大修返回;10.31——Further comments; 11.05——返回编辑部;11.12——通知接收;17.01.03——收到Proof;17.03.10——Early Online; 17.03.20——Publish. , objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151023/IMG5629A2D78CDB25049.jpg, createdBy=12251658553, createdName=sugar661930, createdTime=Sat Mar 25 10:01:00 CST 2017, time=2017-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574022, encodeId=af555e4022b8, content=这个杂志大概外审2个月,回来后要大修,补实验补了一个月,返回后大概过了一个星期,给了Futher commons, 大概改了一个星期修回,但现在还木有消息,想问一下大家都是什么时候接受的,会不会被编辑拒稿呀,好忐忑,求大神指点,十分感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLC6axn6gYictvvbVm0tkM8YjTrvDLLhwvlqibMFQtAfjby2AY4UHAIPKnSqH1Ovp5AgCJY6Ldx6BDw/132, createdBy=bf3b2187804, createdName=Nelly 1993, createdTime=Thu Jul 25 15:43:00 CST 2019, time=2019-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977749, encodeId=ec809e7749af, content=五月十四投的,六月三号给的反馈意见,小修加润色。编辑部要润色证明。然后找了国内的唐山博译润色。结果今天提交后秒拒。这个编辑部把博译相关的润色公司列入黑名单了,而且是秒拒那种。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08bc5311998, createdName=amma229, createdTime=Mon Jun 28 22:57:23 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913998, encodeId=ff3391399829, content=被中科院列为中度预警的期刊,投这个还能毕业吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d375190834, createdName=14717fcdm36(暂无昵称), createdTime=Tue Jan 05 22:34:16 CST 2021, time=2021-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893480, encodeId=7243893480f7, content=想问一下各位,这个杂志submitted状态之后直接是under review吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201025/8eb3ba664d3e470b851a46cc65b07783/2838e99db9824e3ab062239a32b94ea0.jpg, createdBy=e8705227503, createdName=14792e5am71(暂无昵称), createdTime=Wed Oct 21 09:53:30 CST 2020, time=2020-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884742, encodeId=2d12884e4237, content=刚提交了这个杂志,请问后续过程快吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Sat Sep 12 12:12:11 CST 2020, time=2020-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812178, encodeId=d4c88121e89a, content=收综述嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/f0a941924e706deff67f804425f96db6/7b6b2aabb706f19d41b6dc3d8aef6e5c.jpg, createdBy=947b2378049, createdName=wh66ksbs, createdTime=Sat Aug 22 21:58:13 CST 2020, time=2020-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576784, encodeId=16e85e678449, content=是的<span class="quote">135****0862暂无昵称 2019-09-22 00:00:00 发表:<br>这个杂志是非OA期刊也要交版面费?</span>, beContent=135****0862暂无昵称 2019-09-22 00:00:00 发表: 这个杂志是非OA期刊也要交版面费?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/141c3b405ac632875dc5e2f757c9755d.jpg, createdBy=d8912207664, createdName=1085404196_71099776, createdTime=Mon Sep 23 00:00:00 CST 2019, time=2019-09-23, status=1, ipAttribution=)]
    2019-07-25 Nelly 1993

    这个杂志大概外审2个月,回来后要大修,补实验补了一个月,返回后大概过了一个星期,给了Futher commons, 大概改了一个星期修回,但现在还木有消息,想问一下大家都是什么时候接受的,会不会被编辑拒稿呀,好忐忑,求大神指点,十分感谢

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=1096197, encodeId=bdfb109619eda, content=引言中如何全面包含本领域重要研究?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096198, encodeId=31cf10961987b, content=引言中是否可以引用非常老的文章?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534677, encodeId=9eb55346e702, content=恭喜恭喜 太不容易了<span class="quote">Freemori7JR 2017-03-20 发表::<br>研究方向:黑素瘤;; 接收率:约50% 审稿时间:约1个月 7.26投稿;8.30——通知大修;10.25——大修返回;10.31——Further comments; 11.05——返回编辑部;11.12——通知接收;17.01.03——收到Proof;17.03.10——Early Online; 17.03.20——Publish. </span>, beContent=Freemori7JR 2017-03-20 发表:: 研究方向:黑素瘤;; 接收率:约50% 审稿时间:约1个月 7.26投稿;8.30——通知大修;10.25——大修返回;10.31——Further comments; 11.05——返回编辑部;11.12——通知接收;17.01.03——收到Proof;17.03.10——Early Online; 17.03.20——Publish. , objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151023/IMG5629A2D78CDB25049.jpg, createdBy=12251658553, createdName=sugar661930, createdTime=Sat Mar 25 10:01:00 CST 2017, time=2017-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574022, encodeId=af555e4022b8, content=这个杂志大概外审2个月,回来后要大修,补实验补了一个月,返回后大概过了一个星期,给了Futher commons, 大概改了一个星期修回,但现在还木有消息,想问一下大家都是什么时候接受的,会不会被编辑拒稿呀,好忐忑,求大神指点,十分感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLC6axn6gYictvvbVm0tkM8YjTrvDLLhwvlqibMFQtAfjby2AY4UHAIPKnSqH1Ovp5AgCJY6Ldx6BDw/132, createdBy=bf3b2187804, createdName=Nelly 1993, createdTime=Thu Jul 25 15:43:00 CST 2019, time=2019-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977749, encodeId=ec809e7749af, content=五月十四投的,六月三号给的反馈意见,小修加润色。编辑部要润色证明。然后找了国内的唐山博译润色。结果今天提交后秒拒。这个编辑部把博译相关的润色公司列入黑名单了,而且是秒拒那种。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08bc5311998, createdName=amma229, createdTime=Mon Jun 28 22:57:23 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913998, encodeId=ff3391399829, content=被中科院列为中度预警的期刊,投这个还能毕业吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d375190834, createdName=14717fcdm36(暂无昵称), createdTime=Tue Jan 05 22:34:16 CST 2021, time=2021-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893480, encodeId=7243893480f7, content=想问一下各位,这个杂志submitted状态之后直接是under review吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201025/8eb3ba664d3e470b851a46cc65b07783/2838e99db9824e3ab062239a32b94ea0.jpg, createdBy=e8705227503, createdName=14792e5am71(暂无昵称), createdTime=Wed Oct 21 09:53:30 CST 2020, time=2020-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884742, encodeId=2d12884e4237, content=刚提交了这个杂志,请问后续过程快吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Sat Sep 12 12:12:11 CST 2020, time=2020-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812178, encodeId=d4c88121e89a, content=收综述嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/f0a941924e706deff67f804425f96db6/7b6b2aabb706f19d41b6dc3d8aef6e5c.jpg, createdBy=947b2378049, createdName=wh66ksbs, createdTime=Sat Aug 22 21:58:13 CST 2020, time=2020-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576784, encodeId=16e85e678449, content=是的<span class="quote">135****0862暂无昵称 2019-09-22 00:00:00 发表:<br>这个杂志是非OA期刊也要交版面费?</span>, beContent=135****0862暂无昵称 2019-09-22 00:00:00 发表: 这个杂志是非OA期刊也要交版面费?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/141c3b405ac632875dc5e2f757c9755d.jpg, createdBy=d8912207664, createdName=1085404196_71099776, createdTime=Mon Sep 23 00:00:00 CST 2019, time=2019-09-23, status=1, ipAttribution=)]
    2021-06-28 amma229

    五月十四投的,六月三号给的反馈意见,小修加润色。编辑部要润色证明。然后找了国内的唐山博译润色。结果今天提交后秒拒。这个编辑部把博译相关的润色公司列入黑名单了,而且是秒拒那种。

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=1096197, encodeId=bdfb109619eda, content=引言中如何全面包含本领域重要研究?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096198, encodeId=31cf10961987b, content=引言中是否可以引用非常老的文章?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534677, encodeId=9eb55346e702, content=恭喜恭喜 太不容易了<span class="quote">Freemori7JR 2017-03-20 发表::<br>研究方向:黑素瘤;; 接收率:约50% 审稿时间:约1个月 7.26投稿;8.30——通知大修;10.25——大修返回;10.31——Further comments; 11.05——返回编辑部;11.12——通知接收;17.01.03——收到Proof;17.03.10——Early Online; 17.03.20——Publish. </span>, beContent=Freemori7JR 2017-03-20 发表:: 研究方向:黑素瘤;; 接收率:约50% 审稿时间:约1个月 7.26投稿;8.30——通知大修;10.25——大修返回;10.31——Further comments; 11.05——返回编辑部;11.12——通知接收;17.01.03——收到Proof;17.03.10——Early Online; 17.03.20——Publish. , objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151023/IMG5629A2D78CDB25049.jpg, createdBy=12251658553, createdName=sugar661930, createdTime=Sat Mar 25 10:01:00 CST 2017, time=2017-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574022, encodeId=af555e4022b8, content=这个杂志大概外审2个月,回来后要大修,补实验补了一个月,返回后大概过了一个星期,给了Futher commons, 大概改了一个星期修回,但现在还木有消息,想问一下大家都是什么时候接受的,会不会被编辑拒稿呀,好忐忑,求大神指点,十分感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLC6axn6gYictvvbVm0tkM8YjTrvDLLhwvlqibMFQtAfjby2AY4UHAIPKnSqH1Ovp5AgCJY6Ldx6BDw/132, createdBy=bf3b2187804, createdName=Nelly 1993, createdTime=Thu Jul 25 15:43:00 CST 2019, time=2019-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977749, encodeId=ec809e7749af, content=五月十四投的,六月三号给的反馈意见,小修加润色。编辑部要润色证明。然后找了国内的唐山博译润色。结果今天提交后秒拒。这个编辑部把博译相关的润色公司列入黑名单了,而且是秒拒那种。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08bc5311998, createdName=amma229, createdTime=Mon Jun 28 22:57:23 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913998, encodeId=ff3391399829, content=被中科院列为中度预警的期刊,投这个还能毕业吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d375190834, createdName=14717fcdm36(暂无昵称), createdTime=Tue Jan 05 22:34:16 CST 2021, time=2021-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893480, encodeId=7243893480f7, content=想问一下各位,这个杂志submitted状态之后直接是under review吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201025/8eb3ba664d3e470b851a46cc65b07783/2838e99db9824e3ab062239a32b94ea0.jpg, createdBy=e8705227503, createdName=14792e5am71(暂无昵称), createdTime=Wed Oct 21 09:53:30 CST 2020, time=2020-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884742, encodeId=2d12884e4237, content=刚提交了这个杂志,请问后续过程快吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Sat Sep 12 12:12:11 CST 2020, time=2020-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812178, encodeId=d4c88121e89a, content=收综述嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/f0a941924e706deff67f804425f96db6/7b6b2aabb706f19d41b6dc3d8aef6e5c.jpg, createdBy=947b2378049, createdName=wh66ksbs, createdTime=Sat Aug 22 21:58:13 CST 2020, time=2020-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576784, encodeId=16e85e678449, content=是的<span class="quote">135****0862暂无昵称 2019-09-22 00:00:00 发表:<br>这个杂志是非OA期刊也要交版面费?</span>, beContent=135****0862暂无昵称 2019-09-22 00:00:00 发表: 这个杂志是非OA期刊也要交版面费?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/141c3b405ac632875dc5e2f757c9755d.jpg, createdBy=d8912207664, createdName=1085404196_71099776, createdTime=Mon Sep 23 00:00:00 CST 2019, time=2019-09-23, status=1, ipAttribution=)]
    2021-01-05 14717fcdm36(暂无昵称)

    被中科院列为中度预警的期刊,投这个还能毕业吗?

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=1096197, encodeId=bdfb109619eda, content=引言中如何全面包含本领域重要研究?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096198, encodeId=31cf10961987b, content=引言中是否可以引用非常老的文章?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534677, encodeId=9eb55346e702, content=恭喜恭喜 太不容易了<span class="quote">Freemori7JR 2017-03-20 发表::<br>研究方向:黑素瘤;; 接收率:约50% 审稿时间:约1个月 7.26投稿;8.30——通知大修;10.25——大修返回;10.31——Further comments; 11.05——返回编辑部;11.12——通知接收;17.01.03——收到Proof;17.03.10——Early Online; 17.03.20——Publish. </span>, beContent=Freemori7JR 2017-03-20 发表:: 研究方向:黑素瘤;; 接收率:约50% 审稿时间:约1个月 7.26投稿;8.30——通知大修;10.25——大修返回;10.31——Further comments; 11.05——返回编辑部;11.12——通知接收;17.01.03——收到Proof;17.03.10——Early Online; 17.03.20——Publish. , objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151023/IMG5629A2D78CDB25049.jpg, createdBy=12251658553, createdName=sugar661930, createdTime=Sat Mar 25 10:01:00 CST 2017, time=2017-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574022, encodeId=af555e4022b8, content=这个杂志大概外审2个月,回来后要大修,补实验补了一个月,返回后大概过了一个星期,给了Futher commons, 大概改了一个星期修回,但现在还木有消息,想问一下大家都是什么时候接受的,会不会被编辑拒稿呀,好忐忑,求大神指点,十分感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLC6axn6gYictvvbVm0tkM8YjTrvDLLhwvlqibMFQtAfjby2AY4UHAIPKnSqH1Ovp5AgCJY6Ldx6BDw/132, createdBy=bf3b2187804, createdName=Nelly 1993, createdTime=Thu Jul 25 15:43:00 CST 2019, time=2019-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977749, encodeId=ec809e7749af, content=五月十四投的,六月三号给的反馈意见,小修加润色。编辑部要润色证明。然后找了国内的唐山博译润色。结果今天提交后秒拒。这个编辑部把博译相关的润色公司列入黑名单了,而且是秒拒那种。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08bc5311998, createdName=amma229, createdTime=Mon Jun 28 22:57:23 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913998, encodeId=ff3391399829, content=被中科院列为中度预警的期刊,投这个还能毕业吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d375190834, createdName=14717fcdm36(暂无昵称), createdTime=Tue Jan 05 22:34:16 CST 2021, time=2021-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893480, encodeId=7243893480f7, content=想问一下各位,这个杂志submitted状态之后直接是under review吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201025/8eb3ba664d3e470b851a46cc65b07783/2838e99db9824e3ab062239a32b94ea0.jpg, createdBy=e8705227503, createdName=14792e5am71(暂无昵称), createdTime=Wed Oct 21 09:53:30 CST 2020, time=2020-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884742, encodeId=2d12884e4237, content=刚提交了这个杂志,请问后续过程快吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Sat Sep 12 12:12:11 CST 2020, time=2020-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812178, encodeId=d4c88121e89a, content=收综述嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/f0a941924e706deff67f804425f96db6/7b6b2aabb706f19d41b6dc3d8aef6e5c.jpg, createdBy=947b2378049, createdName=wh66ksbs, createdTime=Sat Aug 22 21:58:13 CST 2020, time=2020-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576784, encodeId=16e85e678449, content=是的<span class="quote">135****0862暂无昵称 2019-09-22 00:00:00 发表:<br>这个杂志是非OA期刊也要交版面费?</span>, beContent=135****0862暂无昵称 2019-09-22 00:00:00 发表: 这个杂志是非OA期刊也要交版面费?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/141c3b405ac632875dc5e2f757c9755d.jpg, createdBy=d8912207664, createdName=1085404196_71099776, createdTime=Mon Sep 23 00:00:00 CST 2019, time=2019-09-23, status=1, ipAttribution=)]
    2020-10-21 14792e5am71(暂无昵称)

    想问一下各位,这个杂志submitted状态之后直接是under review吗?

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=1096197, encodeId=bdfb109619eda, content=引言中如何全面包含本领域重要研究?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096198, encodeId=31cf10961987b, content=引言中是否可以引用非常老的文章?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534677, encodeId=9eb55346e702, content=恭喜恭喜 太不容易了<span class="quote">Freemori7JR 2017-03-20 发表::<br>研究方向:黑素瘤;; 接收率:约50% 审稿时间:约1个月 7.26投稿;8.30——通知大修;10.25——大修返回;10.31——Further comments; 11.05——返回编辑部;11.12——通知接收;17.01.03——收到Proof;17.03.10——Early Online; 17.03.20——Publish. </span>, beContent=Freemori7JR 2017-03-20 发表:: 研究方向:黑素瘤;; 接收率:约50% 审稿时间:约1个月 7.26投稿;8.30——通知大修;10.25——大修返回;10.31——Further comments; 11.05——返回编辑部;11.12——通知接收;17.01.03——收到Proof;17.03.10——Early Online; 17.03.20——Publish. , objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151023/IMG5629A2D78CDB25049.jpg, createdBy=12251658553, createdName=sugar661930, createdTime=Sat Mar 25 10:01:00 CST 2017, time=2017-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574022, encodeId=af555e4022b8, content=这个杂志大概外审2个月,回来后要大修,补实验补了一个月,返回后大概过了一个星期,给了Futher commons, 大概改了一个星期修回,但现在还木有消息,想问一下大家都是什么时候接受的,会不会被编辑拒稿呀,好忐忑,求大神指点,十分感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLC6axn6gYictvvbVm0tkM8YjTrvDLLhwvlqibMFQtAfjby2AY4UHAIPKnSqH1Ovp5AgCJY6Ldx6BDw/132, createdBy=bf3b2187804, createdName=Nelly 1993, createdTime=Thu Jul 25 15:43:00 CST 2019, time=2019-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977749, encodeId=ec809e7749af, content=五月十四投的,六月三号给的反馈意见,小修加润色。编辑部要润色证明。然后找了国内的唐山博译润色。结果今天提交后秒拒。这个编辑部把博译相关的润色公司列入黑名单了,而且是秒拒那种。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08bc5311998, createdName=amma229, createdTime=Mon Jun 28 22:57:23 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913998, encodeId=ff3391399829, content=被中科院列为中度预警的期刊,投这个还能毕业吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d375190834, createdName=14717fcdm36(暂无昵称), createdTime=Tue Jan 05 22:34:16 CST 2021, time=2021-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893480, encodeId=7243893480f7, content=想问一下各位,这个杂志submitted状态之后直接是under review吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201025/8eb3ba664d3e470b851a46cc65b07783/2838e99db9824e3ab062239a32b94ea0.jpg, createdBy=e8705227503, createdName=14792e5am71(暂无昵称), createdTime=Wed Oct 21 09:53:30 CST 2020, time=2020-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884742, encodeId=2d12884e4237, content=刚提交了这个杂志,请问后续过程快吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Sat Sep 12 12:12:11 CST 2020, time=2020-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812178, encodeId=d4c88121e89a, content=收综述嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/f0a941924e706deff67f804425f96db6/7b6b2aabb706f19d41b6dc3d8aef6e5c.jpg, createdBy=947b2378049, createdName=wh66ksbs, createdTime=Sat Aug 22 21:58:13 CST 2020, time=2020-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576784, encodeId=16e85e678449, content=是的<span class="quote">135****0862暂无昵称 2019-09-22 00:00:00 发表:<br>这个杂志是非OA期刊也要交版面费?</span>, beContent=135****0862暂无昵称 2019-09-22 00:00:00 发表: 这个杂志是非OA期刊也要交版面费?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/141c3b405ac632875dc5e2f757c9755d.jpg, createdBy=d8912207664, createdName=1085404196_71099776, createdTime=Mon Sep 23 00:00:00 CST 2019, time=2019-09-23, status=1, ipAttribution=)]
    2020-09-12 1489114dm38(暂无昵称)

    刚提交了这个杂志,请问后续过程快吗

    1

    展开1条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=1096197, encodeId=bdfb109619eda, content=引言中如何全面包含本领域重要研究?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096198, encodeId=31cf10961987b, content=引言中是否可以引用非常老的文章?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534677, encodeId=9eb55346e702, content=恭喜恭喜 太不容易了<span class="quote">Freemori7JR 2017-03-20 发表::<br>研究方向:黑素瘤;; 接收率:约50% 审稿时间:约1个月 7.26投稿;8.30——通知大修;10.25——大修返回;10.31——Further comments; 11.05——返回编辑部;11.12——通知接收;17.01.03——收到Proof;17.03.10——Early Online; 17.03.20——Publish. </span>, beContent=Freemori7JR 2017-03-20 发表:: 研究方向:黑素瘤;; 接收率:约50% 审稿时间:约1个月 7.26投稿;8.30——通知大修;10.25——大修返回;10.31——Further comments; 11.05——返回编辑部;11.12——通知接收;17.01.03——收到Proof;17.03.10——Early Online; 17.03.20——Publish. , objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151023/IMG5629A2D78CDB25049.jpg, createdBy=12251658553, createdName=sugar661930, createdTime=Sat Mar 25 10:01:00 CST 2017, time=2017-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574022, encodeId=af555e4022b8, content=这个杂志大概外审2个月,回来后要大修,补实验补了一个月,返回后大概过了一个星期,给了Futher commons, 大概改了一个星期修回,但现在还木有消息,想问一下大家都是什么时候接受的,会不会被编辑拒稿呀,好忐忑,求大神指点,十分感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLC6axn6gYictvvbVm0tkM8YjTrvDLLhwvlqibMFQtAfjby2AY4UHAIPKnSqH1Ovp5AgCJY6Ldx6BDw/132, createdBy=bf3b2187804, createdName=Nelly 1993, createdTime=Thu Jul 25 15:43:00 CST 2019, time=2019-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977749, encodeId=ec809e7749af, content=五月十四投的,六月三号给的反馈意见,小修加润色。编辑部要润色证明。然后找了国内的唐山博译润色。结果今天提交后秒拒。这个编辑部把博译相关的润色公司列入黑名单了,而且是秒拒那种。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08bc5311998, createdName=amma229, createdTime=Mon Jun 28 22:57:23 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913998, encodeId=ff3391399829, content=被中科院列为中度预警的期刊,投这个还能毕业吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d375190834, createdName=14717fcdm36(暂无昵称), createdTime=Tue Jan 05 22:34:16 CST 2021, time=2021-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893480, encodeId=7243893480f7, content=想问一下各位,这个杂志submitted状态之后直接是under review吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201025/8eb3ba664d3e470b851a46cc65b07783/2838e99db9824e3ab062239a32b94ea0.jpg, createdBy=e8705227503, createdName=14792e5am71(暂无昵称), createdTime=Wed Oct 21 09:53:30 CST 2020, time=2020-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884742, encodeId=2d12884e4237, content=刚提交了这个杂志,请问后续过程快吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Sat Sep 12 12:12:11 CST 2020, time=2020-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812178, encodeId=d4c88121e89a, content=收综述嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/f0a941924e706deff67f804425f96db6/7b6b2aabb706f19d41b6dc3d8aef6e5c.jpg, createdBy=947b2378049, createdName=wh66ksbs, createdTime=Sat Aug 22 21:58:13 CST 2020, time=2020-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576784, encodeId=16e85e678449, content=是的<span class="quote">135****0862暂无昵称 2019-09-22 00:00:00 发表:<br>这个杂志是非OA期刊也要交版面费?</span>, beContent=135****0862暂无昵称 2019-09-22 00:00:00 发表: 这个杂志是非OA期刊也要交版面费?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/141c3b405ac632875dc5e2f757c9755d.jpg, createdBy=d8912207664, createdName=1085404196_71099776, createdTime=Mon Sep 23 00:00:00 CST 2019, time=2019-09-23, status=1, ipAttribution=)]
    2020-08-22 wh66ksbs

    收综述嘛

    1

    展开1条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=1096197, encodeId=bdfb109619eda, content=引言中如何全面包含本领域重要研究?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=53, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Mon Dec 27 14:52:50 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1096198, encodeId=31cf10961987b, content=引言中是否可以引用非常老的文章?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=67, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534677, encodeId=9eb55346e702, content=恭喜恭喜 太不容易了<span class="quote">Freemori7JR 2017-03-20 发表::<br>研究方向:黑素瘤;; 接收率:约50% 审稿时间:约1个月 7.26投稿;8.30——通知大修;10.25——大修返回;10.31——Further comments; 11.05——返回编辑部;11.12——通知接收;17.01.03——收到Proof;17.03.10——Early Online; 17.03.20——Publish. </span>, beContent=Freemori7JR 2017-03-20 发表:: 研究方向:黑素瘤;; 接收率:约50% 审稿时间:约1个月 7.26投稿;8.30——通知大修;10.25——大修返回;10.31——Further comments; 11.05——返回编辑部;11.12——通知接收;17.01.03——收到Proof;17.03.10——Early Online; 17.03.20——Publish. , objectType=tool_impact_factor, channel=null, level=null, likeNumber=234, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151023/IMG5629A2D78CDB25049.jpg, createdBy=12251658553, createdName=sugar661930, createdTime=Sat Mar 25 10:01:00 CST 2017, time=2017-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=574022, encodeId=af555e4022b8, content=这个杂志大概外审2个月,回来后要大修,补实验补了一个月,返回后大概过了一个星期,给了Futher commons, 大概改了一个星期修回,但现在还木有消息,想问一下大家都是什么时候接受的,会不会被编辑拒稿呀,好忐忑,求大神指点,十分感谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=84, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLC6axn6gYictvvbVm0tkM8YjTrvDLLhwvlqibMFQtAfjby2AY4UHAIPKnSqH1Ovp5AgCJY6Ldx6BDw/132, createdBy=bf3b2187804, createdName=Nelly 1993, createdTime=Thu Jul 25 15:43:00 CST 2019, time=2019-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=977749, encodeId=ec809e7749af, content=五月十四投的,六月三号给的反馈意见,小修加润色。编辑部要润色证明。然后找了国内的唐山博译润色。结果今天提交后秒拒。这个编辑部把博译相关的润色公司列入黑名单了,而且是秒拒那种。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=81, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=08bc5311998, createdName=amma229, createdTime=Mon Jun 28 22:57:23 CST 2021, time=2021-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913998, encodeId=ff3391399829, content=被中科院列为中度预警的期刊,投这个还能毕业吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=168, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5d375190834, createdName=14717fcdm36(暂无昵称), createdTime=Tue Jan 05 22:34:16 CST 2021, time=2021-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893480, encodeId=7243893480f7, content=想问一下各位,这个杂志submitted状态之后直接是under review吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=154, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201025/8eb3ba664d3e470b851a46cc65b07783/2838e99db9824e3ab062239a32b94ea0.jpg, createdBy=e8705227503, createdName=14792e5am71(暂无昵称), createdTime=Wed Oct 21 09:53:30 CST 2020, time=2020-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=884742, encodeId=2d12884e4237, content=刚提交了这个杂志,请问后续过程快吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=160, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=72535313351, createdName=1489114dm38(暂无昵称), createdTime=Sat Sep 12 12:12:11 CST 2020, time=2020-09-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=812178, encodeId=d4c88121e89a, content=收综述嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=125, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://login.medsci.cn/upload/avatar/f0a941924e706deff67f804425f96db6/7b6b2aabb706f19d41b6dc3d8aef6e5c.jpg, createdBy=947b2378049, createdName=wh66ksbs, createdTime=Sat Aug 22 21:58:13 CST 2020, time=2020-08-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=576784, encodeId=16e85e678449, content=是的<span class="quote">135****0862暂无昵称 2019-09-22 00:00:00 发表:<br>这个杂志是非OA期刊也要交版面费?</span>, beContent=135****0862暂无昵称 2019-09-22 00:00:00 发表: 这个杂志是非OA期刊也要交版面费?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=133, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/06/21/141c3b405ac632875dc5e2f757c9755d.jpg, createdBy=d8912207664, createdName=1085404196_71099776, createdTime=Mon Sep 23 00:00:00 CST 2019, time=2019-09-23, status=1, ipAttribution=)]
    2019-09-23 1085404196_71099776

    是的135****0862暂无昵称 2019-09-22 00:00:00 发表:
    这个杂志是非OA期刊也要交版面费?

    135****0862暂无昵称 2019-09-22 00:00:00 发表: 这个杂志是非OA期刊也要交版面费?

    1

    展开1条回复
共500条页码: 3/50页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分